ASO Visual Abstract: Adjuvant Gemcitabine Versus Neoadjuvant/Adjuvant FOLFIRINOX in Resectable Pancreatic Cancer-The Randomized Multicenter Phase II NEPAFOX Trial

Ann Surg Oncol. 2024 Apr 4. doi: 10.1245/s10434-024-15145-8. Online ahead of print.NO ABSTRACTPMID:38575722 | DOI:10.1245/s10434-024-15145-8

Source: Ann Oncol - April 4, 2024 Category: Cancer & Oncology Authors: Thorsten O Goetze Alexander Reichart Ulli S Bankstahl Claudia Pauligk Maria Loose Thomas W Kraus Moustafa Elshafei Wolf O Bechstein J örg Trojan Matthias Behrend Nils Homann Marino Venerito Wolfram Bohle Michael Varvenne Claus Bolling Dirk M Behringer Ka Source Type: research